| Unique ID issued by UMIN | UMIN000057743 |
|---|---|
| Receipt number | R000065986 |
| Scientific Title | Retrospective study of pulmonary hypertension associated with progressive pulmonary fibrosis |
| Date of disclosure of the study information | 2025/05/01 |
| Last modified on | 2026/09/17 17:22:02 |
Retrospective study of pulmonary hypertension associated with progressive pulmonary fibrosis
Retrospective study of pulmonary hypertension associated with progressive pulmonary fibrosis
Retrospective study of pulmonary hypertension associated with progressive pulmonary fibrosis
Retrospective study of pulmonary hypertension associated with progressive pulmonary fibrosis
| Japan |
pulmonary hypertension
| Cardiology | Pneumology |
Others
NO
Pulmonary hypertension associated with interstitial pneumonia has been thought to have a negative prognostic impact. In recent years, novel therapies for this condition have been developed and have attracted much attention. However, most previous studies have focused on idiopathic pulmonary fibrosis (IPF) among interstitial pneumonias. Very few studies have focused on non-IPF.
The purpose of this study was to investigate the association between interstitial pneumonia with progressive pulmonary fibrosis (PPF) and pulmonary hypertension. It is highly significant to investigate the number of potential patients at a time when new treatment methods are being established.
Efficacy
Prevalence of pulmonary hypertension in PPF
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
Those who meet all of the following 1)~3)
1) Age 18 years or older
2) Those who have been diagnosed with interstitial pneumonia
3) Who have undergone echocardiography or right heart catheterization at the Department of Respirology, Chiba University Hospital between January 1, 2017 and December 31, 2021.
Those who meet any of the following criteria
1) Those whose onset of pulmonary hypertension preceded the diagnosis of interstitial pneumonia
2) Patients who have undergone lung transplantation
3) Those who have expressed their refusal to participate in this study through the information disclosure document.
100
| 1st name | Kenichiro |
| Middle name | |
| Last name | Takeda |
Chiba University Hospital
Department of Respirology
2608677
1-8-1 Inohana, Chuo-Ku, Chiba
0432227171
kenichiro.1990.0909@gmail.com
| 1st name | Kenichiro |
| Middle name | |
| Last name | Takeda |
Chiba University Hospital
Department of Respirology
2608677
1-8-1 Inohana, Chuo-Ku, Chiba
0432227171
kenichiro.1990.0909@gmail.com
Chiba University
None
Other
The Observational Research Ethics Committee of Chiba University Hospital
1-8-1 Inohana, Chuo-Ku, Chiba
0432227171
hsp-kansaturinri@chiba-u.jp
NO
| 2025 | Year | 05 | Month | 01 | Day |
Published
139
Seventy-six of 139 had PH. During the 3-year follow-up period, 40 patients died, and six underwent lung transplantation. Among the 61 patients with PPF and 47 with IPF, the prevalence of PH was similar (PPF 60.7% vs IPF 63.8%). The PPF group included more females (57.4% vs 10.6%) and was younger (median 67 vs 74 years). In PPF, PH was not associated with a shorter survival (log-rank p=0.565; HR 1.32). In PPF-PH, multivariable analysis identified the artery/aorta ratio as the only independent factor.
| 2026 | Year | 09 | Month | 17 | Day |
Completed
| 2025 | Year | 02 | Month | 04 | Day |
| 2025 | Year | 02 | Month | 04 | Day |
| 2025 | Year | 02 | Month | 04 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
Prevalence and survival will were observed retrospectivelye
| 2025 | Year | 04 | Month | 30 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065986